Mark Stolper's most recent trade in Radnet Inc was a trade of 275 Common Stock done . Disclosure was reported to the exchange on Dec. 16, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Radnet Inc | D. Stolper Mark | EVP, Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Dec 2024 | 275 | 80,123 (0%) | 0% | 0 | Common Stock | |
Radnet Inc | Mark D. Stolper | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.27 per share. | 10 Jun 2024 | 25,000 | 80,398 (0%) | 0% | 61.3 | 1,531,750 | Common Stock |
Coherus Biosciences Inc | Mark D. Stolper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | |
Radnet Inc | Mark D. Stolper | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 27,276 | 27,276 | - | - | Employee Stock Option (right to buy) | |
Radnet Inc | Mark D. Stolper | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 14,072 | 105,398 (0%) | 0% | 0 | Common Stock | |
Radnet Inc | Mark Stolper D. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 14,558 | 14,558 | - | - | Restricted Stock Units | |
Coherus Biosciences Inc | Mark D. Stolper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 38,250 | 38,250 | - | - | Stock Option (Right to Buy) | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 May 2023 | 900 | 91,326 (0%) | 0% | 0 | Common Stock | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 375 | 92,226 (0%) | 0% | 0 | Common Stock | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 4,854 | 4,854 | - | - | Employee Stock Option (right to buy) | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 2,227 | 2,227 | - | - | Restricted Stock Units | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 27,276 | 27,276 | - | - | Employee Stock Option (right to buy) | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 14,073 | 14,073 | - | - | Restricted Stock Units | |
Coherus Biosciences Inc | Mark D. Stolper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 27,000 | 27,000 | - | - | Stock Option (Right to Buy) | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 29,140 | 29,140 | - | - | Employee stock option (right to buy) | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 13,374 | 13,374 | - | - | Restricted Stock Units | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 10,635 | 10,635 | - | - | Employee stock option (right to buy) | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 4,882 | 4,882 | - | - | Restricted Stock Units | |
Coherus Biosciences Inc | Mark D. Stolper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Mark D. Stolper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Radnet Inc | Mark D. Stolper | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 19,317 | 19,317 | - | - | Restricted Stock Units |